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Abstract
Purpose The pathogenesis of unicameral bone cysts
(UBCs) remains largely unknown. Osteoclasts have been
implicated, but the role of osteoblastic cells has, to date,
not been explored. This study investigated the pathophys-
iology of UBCs by examining the interactions between the
cyst fluid and human bone marrow stromal cells (hBMSCs)
and the effect of the fluid on osteogenesis.
Methods Fluid was aspirated from two UBCs and ana-
lysed for protein, electrolyte and cytokine levels. Graded
concentrations of the fluid were used as culture media for
hBMSCs to determine the effects of the fluid on hBMSC
proliferation and osteogenic differentiation. The fibrocel-
lular lining was analysed histologically and by electron
microscopy.
Results Alkaline phosphatase (ALP) staining of hBMSCs
that were cultured in cyst fluid demonstrated increased cell
proliferation and osteogenic differentiation compared to
basal media controls. Biochemical analysis of these
hBMSCs compared to basal controls confirmed a marked
increase in DNA content (as a marker of proliferation) and
ALP activity (as a marker of osteogenic differentiation)
which was highly significant (p \ 0.001). Osteoclasts were
demonstrated in abundance in the cyst lining. The cyst fluid
cytokine profile revealed levels of the pro-osteoclast
cytokines IL-6, MIP-1a and MCP-1 that were 199, 319
and 359 greater than those in reference serum.
Conclusions Cyst fluid promoted osteoblastic growth and
differentiation. Despite appearing paradoxical that the cyst
fluid promoted osteogenesis, osteoblastic cells are required
for osteoclastogenesis through RANKL signalling. Three
key cytokines in this pathway (IL-6, MIP-1a, MCP-1) were
highly elevated in cyst fluid. These findings may hold the
key to the pathogenesis of UBCs, with implications for
treatment methods.
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Introduction
Unicameral bone cysts (UBCs) are benign bone defects that
are defined as minimally expansile lucent lesions consisting
of a cavity filled with fluid and lined with a fibrocellular
membrane [1]. The pathogenesis of UBCs remains largely
unknown, but theories presented in the literature include
pressure effects due to blocked fluid drainage [2], local
venous obstruction [3, 4], increased lysosomal enzyme
activity [5], prostaglandins [6], nitric oxide [3], oxygen free
radicals [7], disorders of synovial origin [8] and genetic
causes [9]. As these hypotheses concerning the pathogen-
esis of UBCs have evolved, multiple diverse treatment
strategies have emerged. However, theories have often been
based on the analysis of single reports or small case series,
so a unified hypothesis (and hence targeted treatment)
remains elusive. Therapeutic aspiration, curettage [10],
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autologous bone marrow injection [11, 12], steroid injec-
tions [6, 13, 14], demineralised bone matrix [15], grafting of
synthetic materials [16, 17] and intramedullary fixation [18,
19] are routinely employed to treat UBCs, though all have a
high failure and/or recurrence rate.
Much of the literature defining the pathogenesis of
UBCs has suggested a role for osteoclasts. Shindell et al.
[6] have reported increased levels of PGE2 within UBC
fluid. PGE2 is a protein kinase A (PKA)-mediated signal-
ling molecule involved in the stimulation and proliferation
of osteoclasts. A reduction in levels following intralesional
steroid injection has been associated with cyst resolution
[6]. Similarly, osteoclasts require lysosomal enzymes for
bone resorption, and increased levels of these, together
with collagen degradation products, have been demon-
strated in UBCs, indicating ongoing osteoclast-mediated
bone destruction [5]. Increased osteoclast activity within
UBCs has also been established by detecting elevated acid
phosphatase levels [20] and increased osteoclast-related
bone resorptive factors within the cyst fluid and lining [3].
Furthermore, the presence of osteoclasts has also been
confirmed in the fibrocellular lining of UBCs by histology
[3] and electron microscopy [21].
Complex signalling pathways exist between osteoclasts
and cells of the osteoblast lineage [human bone marrow
stromal cells (hBMSCs), osteoblasts, osteocytes and bone
lining cells] [22], abnormalities of which contribute to a
wide range of bone pathologies, including osteoporosis,
osteopetrosis, Paget’s disease, rheumatoid arthritis and
periodontal disease [23, 24]. Differentiation, fusion and
activation of osteoclasts from macrophage-monocyte pre-
cursors are stimulated by factors derived from cells of the
osteoblast lineage, notably RANK ligand (RANKL),
so-called because it binds to a receptor on osteoclast pre-
cursors, receptor activator of NFjB (RANK) [25]. Cells
expressing the osteoblast markers Stro-1 and RUNX-2
have been identified in the UBC fibrocellular lining, and
these have been shown to induce osteoclastogenesis in
vitro [21]. Beyond this single manuscript, the role of cells
of the osteoblast lineage in the pathogenesis of UBCs has
not been explored. Furthermore, whilst many of the
abnormalities that have been identified in UBCs have been
discovered by analysing the cyst fluid [3, 5–7, 20], the
effect that the fluid itself contributes to UBC pathology
has, to date, not been investigated.
Aims
The purpose of this study was to explore the underlying
pathophysiology of unicameral bone cysts (UBCs) by
investigating the relationship between cells of the osteo-
blast lineage and the cyst fluid.
Materials and methods
Cyst fluid from UBCs of two patients was analysed for this
study. The use of human tissue was prospectively approved
by the local regional ethics committee (LREC194/99/1)
and informed parental consent was obtained.
Case 1
A nine-year-old healthy male had a one-year history of
progressive pain in his right thigh, and radiographic inves-
tigation revealed a lesion of the proximal femur character-
istic of a UBC (Fig. 1a, b). Due to the risk of impending
fracture, the patient was listed for surgical stabilisation.
Under general anaesthetic and fluoroscopic guidance, 20 ml
of straw-coloured fluid was aspirated percutaneously from
the cyst in the proximal femur (Fig. 1c), prior to stabilisation
with a flexible intramedullary nail (Fig. 1d).
Case 2
A six-year-old boy suffered a pathological fracture through
a previously asymptomatic unicameral bone cyst of his
right proximal humerus. The fractured cortices progressed
to bony union, but the cyst remained, and required surgical
stabilisation (Fig. 1e, f). Intraoperatively, 4 ml of straw-
coloured fluid was aspirated percutaneously (Fig. 1g), and
a window of bone and UBC membrane was excised from
the medial wall. The proximal humerus was stabilised with
a flexible intramedullary nail (Fig. 1h).
Cyst fluid separation
The aspirated samples were centrifuged at 1,100 rpm for
4 min at 21 C to separate the supernatant, which was
removed, providing a pure fluid fraction which was used
for further analysis.
Harvesting of human cells of the osteoblast lineage
Bone marrow is a reliable source of human bone marrow
stromal cells (hBMSCs), which have the potential for self-
renewal and osteogenic differentiation [25]. Human bone
marrow was obtained for this study from haematologically
normal adults undergoing routine total hip replacement
surgery with the approval of the local ethics committee
(LREC194/99/1). Adult hBMSCs were harvested by
repeatedly washing the marrow in 0.9 % saline, centrifu-
gation, passage through a 70 lm filter and culture expan-
sion in basal media at 37 C in 4 % humidified CO2. At
30 % confluence, the adult hBMSCs were released using
trypsin in EDTA (ethylene diamine tetraacetic acid), cen-
trifuged, re-suspended in basal media and a cell count was
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performed using a haemocytometer. The hBMSC solution
was titrated to a concentration of 5 9 103 hBMSCs per
100 ll of basal media prior to seeding onto culture plates
(n = 18).
hBMSC culture in cyst fluid
Graded concentrations of cyst fluid were prepared by
mixing with alpha-modified Eagle’s medium (a-MEM) as
an inert control. One hundred microlitre aliquots of graded
cyst fluid/a-MEM mixes were added to 100 ll aliquots of
hBMSCs in basal media in culture wells. This provided
eighteen 200 ll aliquots of culture media/cyst fluid/a-
MEM, each containing 5 9 103 hBMSCs. Cyst fluid con-
centrations were 0, 25 and 50 %, with six identical wells of
each concentration prepared (Table 1). Cultures were run
for eight days then fixed in 95 % ethanol for analysis.
Alkaline phosphatase stain
Following fixation in 95 % ethanol for 24 h, hBMSCs were
stained with Naphthol AS-MX and Fast Violet B Salts
(Sigma-Aldrich, Poole, UK) for alkaline phosphatase
(ALP) to measure the osteogenic differentiation of
hBMSCs. Microscope images were recorded using Carl
Zeiss Axiovision software v.3.0 via an AxioCam HR dig-
ital camera on an Axiovert 200 inverted microscope (Carl
Zeiss Ltd, Welwyn Garden City, UK).
Biochemical analysis
Culture wells were assessed by biochemical analysis for
DNA content (as a measure of total cell number), and ALP
activity (as a measure of osteogenic differentiation). Fol-
lowing fixation in 95 % ethanol, cell lysates were obtained
via three sequential freeze–thaw cycles in Triton X-100
(BDH Chemical Ltd, Poole, UK). ALP and DNA assays
Fig. 1 Radiographs of UBCs from cases 1 and 2: preoperative AP
and lateral radiographs of case 1 (a, b proximal femur) and case 2 (e,
f proximal humerus). Intraoperative fluoroscopy of percutaneous
aspiration and cystogram, followed by stabilisation with flexible
nailing, of case 1 (c, d) and case 2 (g, h)
Table 1 The proportions of cyst fluid, a-MEM and basal media in
each culture well, illustrating how the % value of cyst fluid was
derived
% of cyst fluid in culture media 0 % 25 % 50 %
n = 6 n = 6 n = 6
Cell number 5 9 103 5 9 103 5 9 103
Cyst fluid volume/ll 0 50 100
a-MEM fluid volume/ll 100 50 0
Basal media volume/ll 100 100 100
Total media volume/ll 200 200 200
For each category, n = 12, and this was replicated for both cases
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were then performed in a standard manner with 10 ll of
lysate run in triplicate for each concentration of cyst fluid
on a plate against two standards, and read on a BioTek
KC4 ELx800 absorbance microplate reader and FLx800
fluorescence microplate reader (BioTek, Potton, UK),
respectively. Statistical analysis was performed by one-
way ANOVA using GraphPad InStat v.3.00 (GraphPad
Software, San Diego, CA, USA).
Analysis of protein, electrolytes and cytokines
of the cyst fluid
The levels of a range of musculoskeletal cytokines in cyst
fluid supernatant were assessed using fluorescent bead
immunoassay and flow cytometry (Human Chemokine
6plex BMS813FF plate, Bender MedSystems, Vienna,
Austria), which tested for levels of granulocyte colony
stimulating factor (G-CSF), interferon-gamma (IFN-c),
interleukin (IL)-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10,
IL-12p70, monocyte chemotactic protein (MCP)-1, mono-
kine induced by gamma interferon (MIG), macrophage
inflammatory protein (MIP)-1a, MIP-1b, tumour necrosis
factor (TNF)-a and TNF-b. Protein and electrolyte levels
were measured using a Beckman DXC Coulter Counter
(Beckman Coulter Ltd, High Wycombe, UK).
Analysis of fibrocellular lining of cyst
Samples were fixed in 4 % paraformaldehyde and freeze
dried. SEM analysis was performed using a JSM 6330F
scanning electron microscope (JEOL UK Ltd, Welwyn
Garden City, UK) and an ISIS 300 system (Oxford
Instruments, Abingdon, UK) was used to obtain energy-
dispersive X-ray analysis (EDXA) data on the samples.
Tissue was dehydrated using increasing concentrations of
ethanol prior to wax imbedding, sectioning and staining
with toluidine blue for analysis of structural detail.
Results
ALP staining of hBMSC culture with cyst fluid
ALP staining of hBMSCs in 25 and 50 % cyst fluid (n = 3)
demonstrated increased cell proliferation and osteogenic
differentiation compared to cells cultured in basal media.
This was observed to be dose dependent (Fig. 2a–c).
Biochemical analysis of hBMSC culture with cyst fluid
hBMSC culture in graded cyst fluid concentrations from
both cysts showed significantly increased ALP activity
(p \ 0.001), DNA activity (p \ 0.001) and ALP-specific
activity (p \ 0.001) compared to cells exposed to basal
media alone. This finding was observed to be dose
dependent with increasing cyst fluid concentration from 0
to 50 %, displaying the promotion of osteogenic differen-
tiation of hBMSCs by UBC fluid and providing quantifi-
cation of the qualitative observations of ALP staining
(Fig. 3a–f).
Fibrocellular membrane
The fibrocellular membrane that was excised from the cyst
of patient 2 showed osteoclast-like giant cells with multiple
nuclei and numerous mitochondria on EM (Fig. 4a) and
Fig. 2 Photomicroscope images of ALP-stained hBMSC cultures in graded cyst fluid concentrations [0 % (a, d), 25 % (b, e), 50 % (c, f)]
showed increased cell proliferation and ALP staining with increased cyst fluid concentrations. Scale bars 200 lm
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histology (Fig. 4b), in keeping with reports by Komiya
et al. [3] and Yu et al. [21]. Interestingly, an abundance of
osteoclasts in the paratrabecular region of the cyst lining
was demonstrated (Fig. 4b).
Protein and electrolyte levels
Levels of sodium, potassium, bicarbonate and calcium in
the cyst fluid were within the normal range for plasma, and
protein was 54 g/l, in keeping with previous analyses of
cyst fluid [2, 4].
Cytokine levels
Elevated levels of three out of the panel of 15 musculo-
skeletal cytokines were recorded (Table 2). IL-6, MIP-1a
and MCP-1 levels were increased by 19, 31 and 35 times,
respectively, compared to reference values found in the
literature [26–28]. This contrasted with all other cytokines
tested, which were either below the level of detection or
below published reference values. Therefore, for clarity,
these are not presented in the table.
Discussion
The typical radiographic appearance of a UBC is an eroded
cyst cavity (Fig. 1), and a role has been proposed for
osteoclasts in UBC pathology [3, 5, 6, 20, 21]. The EM and
histological sections in this study revealed once again the
presence of osteoclasts in high numbers in the cyst lining
(Fig. 4). It may appear paradoxical therefore that potenti-
ation of cells of the osteoblast lineage by the cyst fluid
was observed; biochemical and histological analysis
Fig. 3 Biochemical assays of hBMSCs cultured with graded concentrations of cyst fluid from cyst 1 (left column) and cyst 2 (right column).
Error bars denote the standard deviation, ***p \ 0.001. Each assay was run in triplicate
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demonstrated a marked increase in hBMSC proliferation
and osteogenic differentiation when cultured in the pres-
ence of cyst fluid, which was highly significant (p \ 0.001)
(Figs. 2, 3).
On the basis of these results, increased osteogenesis
could be the expected pathology, as opposed to the eroded
bone appearances typically seen on radiographs of UBCs.
However, complex signalling pathways exist between cells
of the osteoblast lineage and osteoclasts, notably through
the release of RANKL, without which osteoclasts neither
form nor function [23, 24, 29]. As well as establishing
promotion of cells of the osteoblast lineage by the cyst
fluid, this study also identified—for the first time—a
number of pro-osteoclast cytokines within the cyst fluid,
with dramatically increased levels of RANKL-related
osteoclast-promoting cytokines: IL-6, MCP-1 and MIP-1a.
IL-6 is a key cytokine in the promotion of bone
resorption by osteoclasts [24, 30, 31], acting via Gp130
signalling of cells of the osteoblast lineage to induce
RANKL. Normal physiological levels of IL-6 in the cir-
culation are below the level of detection [23], but were
grossly elevated in UBC fluid. Notably, IL-6 acts via a
different signalling pathway to the PKA-mediated promo-
tion of RANKL by PGE2, which has also been shown to be
elevated in cyst fluid [6]. Upregulation of IL-6 has been
implicated in osteoclastogenesis causing osteoporosis [32,
33], and with pathological bone resorption in multiple
myeloma [33]. Increased IL-6 levels in UBC fluid have
been reported once previously, though the authors made
negligible comment on this finding [3].
Monocyte chemotactic protein-1 (MCP-1) is induced by
RANKL to promote osteoclast differentiation from mono-
cyte precursors. A positive feedback loop exists, as MCP-1
is released by osteoclasts upon differentiation [34]. MCP-1
activity has been linked to osteoclastogenesis and osteo-
clast activity of bone metastases [28].
Macrophage inflammatory protein-1a (MIP-1a) is
potently stimulated by RANKL to promote chemotaxis of
human osteoclast precursors and differentiation to mature
osteoclasts [34]. MIP-1a-mediated osteoclast formation has
been implicated in osteolysis caused by multiple myeloma
[35]. An MCP-1/MIP-1a/RANKL autocrine loop has been
described and, interestingly, this mechanism was hypoth-
esised to cause pathology when chemokines are abundant
[34].
Thus, the increased levels of MCP-1, MIP-1a and IL-6
detected in the cyst fluid provide a mechanism for the
enhanced osteoclast activity and the macroscopic appear-
ance of bone erosion seen within a UBC (Fig. 5). The
promotion of hBMSC activity by cyst fluid provides an
Fig. 4 Electron micrograph (EM) and histological section of the fibrocellular lining of the UBC. a EM demonstrated large osteoclast-like cells
with multiple nuclei (arrows). b Histological images of the cyst wall revealed multiple osteoclasts in the paratrabecular region (arrows)
Table 2 High levels of three cytokines were recorded in the cyst
fluid
Cytokine Level
(pg/ml)
Reference level for
serum (pg/ml)
Fold
increase
IL-6 20.91 1.1 [26] 199
Macrophage
inflammatory protein
(MIP-1a)
400.7 13.0 [27] 319
Monocyte chemotactic
protein (MCP-1)
1,852 53.0 [28] 359
Fig. 5 Flow chart of the RANKL signalling pathway, illustrating the
dependence of osteoclasts on osteoblasts for their function, and the
role of MCP-1, MIP-1a and IL-6
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explanation for cytokine upregulation—through the
RANKL signalling pathway. Osteoblasts are known to
stimulate osteoclast growth and differentiation through the
release of RANKL [23], though osteocytes and bone lining
cells have also been associated with RANKL release and
osteoclast function [22, 36, 37]. Whilst the cyst fluid may
be a reflection of the initial pathogenesis of UBCs, the
source of the elevated cytokines remains unclear, and
further work is necessary to identify this.
Like most other studies on UBCs, this study consists of a
small sample size, and more patients are required. The
musculoskeletal cytokine panel used in this study did not
include RANKL, the levels of which are important to
verify the theory presented here. Furthermore, studies on
the effect of cyst fluid when cultured with osteoclasts are
planned.
RANKL-mediated upregulation of osteoclasts may hold
the key to the pathogenesis of UBCs, and further studies
are planned to explore this hypothesis further. Novel ave-
nues for UBC treatment may therefore need to be directed
at downregulation of the pro-osteoclast cytokines. Reso-
lution of these defects by targeted medical therapies to
restore the normal osteoblast/osteoclast signalling may
reduce the high failure rate of current therapies and avoid
the requirement for invasive intervention in this group of
patients.
Acknowledgments The authors are grateful to Esther Ralph for
technical laboratory support. The assistance of Dr Paul Noakes, for
cytokine analysis, and Sue Cox, electron microscopist in the Bio-
medical Imaging Unit, for the production of the EM images and slide
preparation of the cyst lining, is gratefully acknowledged. Surgical
costs were funded by the National Health Service (NHS), and labo-
ratory costs were funded by grants awarded from the Biotechnology
and Biological Sciences Research Council (BBSRC) and the Medical
Research Council (MRC).
Conflict of interest None.
References
1. Capanna R, Campanacci DA, Manfrini M (1996) Unicameral and
aneurysmal bone cysts. Orthop Clin North Am 27(3):605–614
2. Cohen J (1960) Simple bone cysts. Studies of cyst fluid in six
cases with a theory of pathogenesis. J Bone Joint Surg Am
42-A:609–616
3. Komiya S, Kawabata R, Zenmyo M, Hashimoto S, Inoue A
(2000) Increased concentrations of nitrate and nitrite in the cyst
fluid suggesting increased nitric oxide synthesis in solitary bone
cysts. J Orthop Res 18(2):281–288
4. Chigira M, Maehara S, Arita S, Udagawa E (1983) The aetiology
and treatment of simple bone cysts. J Bone Joint Surg Br
65(5):633–637
5. Gerasimov AM, Toporova SM, Furtseva LN, Berezhnoy AP,
Vilensky EV, Alekseeva RI (1991) The role of lysosomes in the
pathogenesis of unicameral bone cysts. Clin Orthop Relat Res
266:53–63
6. Shindell R, Huurman WW, Lippiello L, Connolly JF (1989)
Prostaglandin levels in unicameral bone cysts treated by intrale-
sional steroid injection. J Pediatr Orthop 9(5):516–519
7. Komiya S, Tsuzuki K, Mangham DC, Sugiyama M, Inoue A
(1994) Oxygen scavengers in simple bone cysts. Clin Orthop
Relat Res 308:199–206
8. Mirra JM, Bernard GW, Bullough PG, Johnston W, Mink G
(1978) Cementum-like bone production in solitary bone cysts.
(so-called ‘‘cementoma’’ of long bones). Report of three cases.
Electron microscopic observations supporting a synovial origin to
the simple bone cyst. Clin Orthop Relat Res 135:295–307
9. Vayego SA, De Conti OJ, Varella-Garcia M (1996) Complex
cytogenetic rearrangement in a case of unicameral bone cyst.
Cancer Genet Cytogenet 86(1):46–49
10. Cohen J (1977) Unicameral bone cysts. A current synthesis of
reported cases. Orthop Clin North Am 8(4):715–736
11. Docquier PL, Delloye C (2003) Treatment of simple bone cysts
with aspiration and a single bone marrow injection. J Pediatr
Orthop 23(6):766–773
12. Lokiec F, Ezra E, Khermosh O, Wientroub S (1996) Simple bone
cysts treated by percutaneous autologous marrow grafting. A
preliminary report. J Bone Joint Surg Br 78(6):934–937
13. Scaglietti O, Marchetti PG, Bartolozzi P (1979) The effects of
methylprednisolone acetate in the treatment of bone cysts.
Results of three years follow-up. J Bone Joint Surg Br 61-B(2):
200–204
14. Capanna R, Dal MA, Gitelis S, Campanacci M (1982) The nat-
ural history of unicameral bone cyst after steroid injection. Clin
Orthop Relat Res 166:204–211
15. Rougraff BT, Kling TJ (2002) Treatment of active unicameral
bone cysts with percutaneous injection of demineralized bone
matrix and autogenous bone marrow. J Bone Joint Surg Am
84-A(6):921–929
16. Thawrani D, Thai CC, Welch RD, Copley L, Johnston CE (2009)
Successful treatment of unicameral bone cyst by single percuta-
neous injection of alpha-BSM. J Pediatr Orthop 29(5):511–517
17. Sponer P, Urban K (2004) Treatment of juvenile bone cysts by
curettage and filling of the cavity with BAS-0 bioactive glass-
ceramic material. Acta Chir Orthop Traumatol Cech 71(4):214–
219
18. Roposch A, Saraph V, Linhart WE (2000) Flexible intramedul-
lary nailing for the treatment of unicameral bone cysts in long
bones. J Bone Joint Surg Am 82-A(10):1447–1453
19. de Sanctis N, Andreacchio A (2006) Elastic stable intramedullary
nailing is the best treatment of unicameral bone cysts of the long
bones in children? Prospective long-term follow-up study. J Pe-
diatr Orthop 26(4):520–525
20. Markovic B, Cvijetic A, Karakasevic J (1988) Acid and alkaline
phosphatase activity in bone-cyst fluid. J Bone Joint Surg Br
70(1):27–28
21. Yu J, Chang SS, Suratwala S, Chung WS, Abdelmessieh P, Lee
HJ et al (2005) Zoledronate induces apoptosis in cells from fibro-
cellular membrane of unicameral bone cyst (UBC). J Orthop Res
23(5):1004–1012
22. Xiong J, O’Brien CA (2012) Osteocyte RANKL: new insights
into the control of bone remodeling. J Bone Miner Res 27(3):
499–505
23. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N
(1995) Modulation of osteoclast differentiation by local factors.
Bone 17(2 Suppl):87S–91S
24. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y,
Athanasou NA (2003) Interleukin-6 and interleukin-11 support
human osteoclast formation by a RANKL-independent mecha-
nism. Bone 32(1):1–7
25. Oreffo RO, George S, Rassoulian H, Davies E, Roach T, Dunlop
DG, et al. (2007) Musculoskeletal biology, biomechanics, disease
J Child Orthop (2012) 6:339–346 345
123
and regeneration (Basic Science Regional Course). University of
Southampton, Southampton
26. Grey A, Mitnick MA, Shapses S, Ellison A, Gundberg C, Insogna
K (1996) Circulating levels of interleukin-6 and tumor necrosis
factor-alpha are elevated in primary hyperparathyroidism and
correlate with markers of bone resorption—a clinical research
center study. J Clin Endocrinol Metab 81(10):3450–3454
27. Politou M, Terpos E, Anagnostopoulos A, Szydlo R, Laffan M,
Layton M et al (2004) Role of receptor activator of nuclear
factor-kappa B ligand (RANKL), osteoprotegerin and macro-
phage protein 1-alpha (MIP-1a) in monoclonal gammopathy of
undetermined significance (MGUS). Br J Haematol 126(5):686–
689
28. Cai Z, Chen Q, Chen J, Lu Y, Xiao G, Wu Z et al (2009)
Monocyte chemotactic protein 1 promotes lung cancer-induced
bone resorptive lesions in vivo. Neoplasia 11(3):228–236
29. Arnett TR (2008) Extracellular pH regulates bone cell function.
J Nutr 138(2):415S–418S
30. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S,
Findlay DM et al (1995) Interleukin (IL)-6 induction of osteoclast
differentiation depends on IL-6 receptors expressed on osteo-
blastic cells but not on osteoclast progenitors. J Exp Med
182(5):1461–1468
31. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y et al
(1990) IL-6 is produced by osteoblasts and induces bone
resorption. J Immunol 145(10):3297–3303
32. Manolagas SC (1995) Role of cytokines in bone resorption. Bone
17(2 Suppl):63S–67S
33. Ancey C, Kuster A, Haan S, Herrmann A, Heinrich PC, Muller-
Newen G (2003) A fusion protein of the gp130 and interleukin-
6Ralpha ligand-binding domains acts as a potent interleukin-6
inhibitor. J Biol Chem 278(19):16968–16972
34. Kim MS, Magno CL, Day CJ, Morrison NA (2006) Induction of
chemokines and chemokine receptors CCR2b and CCR4 in
authentic human osteoclasts differentiated with RANKL and
osteoclast like cells differentiated by MCP-1 and RANTES.
J Cell Biochem 97(3):512–518
35. Oyajobi BO, Franchin G, Williams PJ, Pulkrabek D, Gupta A,
Munoz S et al (2003) Dual effects of macrophage inflammatory
protein-1alpha on osteolysis and tumor burden in the murine
5TGM1 model of myeloma bone disease. Blood 102(1):311–319
36. Eriksen EF, Eghbali-Fatourechi GZ, Khosla S (2007) Remodel-
ing and vascular spaces in bone. J Bone Miner Res 22(1):1–6
37. O’Brien CA, Plotkin LI, Galli C, Goellner JJ, Gortazar AR, Allen
MR et al (2008) Control of bone mass and remodeling by PTH
receptor signaling in osteocytes. PLoS One 3(8):e2942
346 J Child Orthop (2012) 6:339–346
123
